Literature DB >> 28662227

Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration.

Rita F Redberg1, Alison F Jacoby2, Joshua M Sharfstein3.   

Abstract

Mesh：

Year:  2017        PMID： 28662227     DOI： 10.1001/jama.2017.7704

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Practical Improvements for Medical Device Evaluation.

Authors:  Daniel B Kramer; Robert W Yeh
Journal:  JAMA       Date:  2017-07-25       Impact factor: 56.272

2.  Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements.

Authors:  Sarah Y Zheng; Sanket S Dhruva; Rita F Redberg
Journal:  JAMA       Date:  2017-08-15       Impact factor: 56.272
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.